Medically reviewed by Dr. Giovanni Scornavacca — Hair Restoration Specialist, Carisma Hair Clinic, St Julian's, Malta. 20+ years clinical experience, trained in Rome and Bologna.

Medically reviewed by Dr. Giovanni Scornavacca — Hair Restoration Specialist, Carisma Hair Clinic, St Julian's, Malta. 20+ years clinical experience.

Minoxidil Foam vs Solution: Which Formulation Should You Use?

Minoxidil foam and solution contain the same active ingredient at the same concentration. Clinical evidence considers them comparable in efficacy. The meaningful differences lie in the carrier chemicals, drying time, scalp tolerability, and cost. Foam avoids propylene glycol — the primary cause of contact dermatitis in solution users — dries in minutes, and suits active lifestyles. Solution penetrates more readily on dense hair and is generally less expensive. For most patients, the best formulation is the one applied consistently. Results may vary for each individual.

Contents

• ›What Is Actually in Each Formulation
• ›Why Propylene Glycol Matters: Scalp Irritation
• ›Penetration and Absorption: Solution on Dense Hair
• ›Drying Time and Daily Routine
• ›Cost in Malta: Solution Is Generally Cheaper
• ›The Shedding Question
• ›Choosing for Your Situation
• ›When to Switch Formulations Mid-Treatment
• ›Frequently Asked Questions About Minoxidil Foam vs Solution in Malta

You have done the research. You have decided that minoxidil is the appropriate next step. Now a more specific question has appeared: foam or solution?

It is a reasonable question. Both products sit on pharmacy shelves with similar packaging, the same active ingredient listed on the label, and price differences that can vary by a factor of two or three depending on which formulation and which brand you choose. The clinical literature does not provide a clean winner — no large head-to-head randomised trial has compared foam against solution on hair density endpoints with definitive results. What it does provide is a clear picture of the differences that matter in practice: the carrier chemicals, how each formulation interacts with your scalp, how quickly each dries, and what happens when scalp sensitivity becomes a problem.

This article works through each of those differences. By the end, you will have a specific reason to prefer one formulation for your situation — or confirmation that either may serve you equally well if you apply it correctly. If you are still deciding whether minoxidil is right for you at all, the broader question is covered in the guide to minoxidil in Malta.

What Is Actually in Each Formulation

Both minoxidil foam and solution contain the same active molecule — minoxidil — at the same concentrations (2% for women, 5% for men in the standard topical formulations). The distinction between them is not the drug itself. It is what carries the drug to the scalp.

Minoxidil solution uses propylene glycol as its primary carrier solvent. Propylene glycol is a humectant — it draws moisture and helps the active ingredient penetrate into the scalp tissue. It also gives solution its characteristic slightly viscous, slightly tacky quality when applied.

Minoxidil foam replaces propylene glycol with ethanol (alcohol) as the primary solvent, delivered through a pressurised canister. When the foam is dispensed and applied to the scalp, the alcohol evaporates rapidly, leaving behind the minoxidil. There is no propylene glycol.

This difference in carrier chemistry is the single most clinically meaningful distinction between the two formulations. Everything else — drying time, skin tolerance, application behaviour — flows from it. A topical minoxidil review published in Dermatologic Therapy confirms that therapeutic equivalence between foam and solution is well-supported, with the carrier composition being the key variable affecting tolerability rather than efficacy.

Before reviewing the treatment options available through a specialist hair loss treatment Malta clinic, understanding what you are putting on your scalp each day is worth a few minutes.

Why Propylene Glycol Matters: Scalp Irritation

Propylene glycol is well-tolerated by most people. However, it is also among the most common causes of contact dermatitis from topical hair loss products. In clinical practice, scalp redness, persistent itching, flaking, and a burning sensation that begins shortly after application are frequently attributable not to the minoxidil molecule itself but to the propylene glycol carrier.

This distinction matters because many patients who experience scalp irritation with solution assume they cannot tolerate minoxidil at all — and stop treatment. In a meaningful proportion of those cases, the issue is the carrier, not the active ingredient. Switching to a foam formulation resolves the irritation while preserving access to the treatment.

Clinically, the sequence to follow when scalp irritation arises on solution is:

1. ›Confirm the irritation is application-site-specific (scalp, not face or surrounding skin) and follows a consistent pattern after application.
2. ›Ensure application technique is correct — solution should be applied to a dry scalp in small quantities; over-application worsens irritation.
3. ›If irritation persists after two to four weeks despite correct technique, consider switching to foam before concluding that minoxidil cannot be tolerated.

For patients who have never experienced propylene glycol sensitivity, the risk of dermatitis from solution is low. It becomes a relevant consideration if you have a history of skin sensitivity, eczema, or known reactions to propylene glycol-containing products. Clinical evidence suggests that the decision to switch from solution to foam should be based on scalp tolerance rather than a preference for either formulation.

Penetration and Absorption: Solution on Dense Hair

Twice-daily application, sustained over 12 months or more, is where results are made or lost. Photo: Ketut Subiyanto / Pexels

One of the less-discussed practical differences between the two formulations concerns how each behaves when applied to hair of varying density.

Minoxidil solution is a liquid. When dispensed using the dropper applicator, it can be directed precisely to the scalp surface and, if massaged gently, may penetrate even through thicker overlying hair. The liquid nature allows it to reach the follicle-bearing scalp tissue without requiring extensive parting.

Minoxidil foam is dispensed as a mousse-like substance. It is designed to be applied to the fingertips and worked into the scalp. On a scalp with short or sparse hair, this works well. On a scalp with dense, thick, or longer hair, getting the foam to contact the scalp surface — rather than sitting on top of the hair shaft — requires more deliberate parting and manual distribution.

For men with significant thinning or very short hair, this distinction is minimal. For men who are in the earlier stages of androgenetic alopecia with substantial remaining hair density, it is worth keeping in mind.

The practical recommendation: if you have dense hair and choose foam, part your hair deliberately before application, work the foam section by section, and use your fingertips to work it into the scalp tissue rather than simply pressing the foam against the hair surface.

Drying Time and Daily Routine

This is where the formulations diverge most noticeably in daily practice.

Minoxidil solution takes significantly longer to dry — typically 20 to 30 minutes before you can safely apply styling products, wear a hat, or go to bed without transferring the product onto a pillow. Applied at night, solution may still be detectably damp when you lie down. Some patients apply it an hour before sleep; others apply it first thing in the morning when they can wait. In warm, humid conditions, the drying window extends further.

Minoxidil foam dries in approximately three to five minutes after application. The alcohol carrier evaporates quickly, leaving the scalp feeling dry and comfortable shortly after application. Foam integrates into a morning routine without disrupting it — apply, wait a few minutes while brushing your teeth, and continue as normal.

For patients who require twice-daily applications (the standard protocol for most minoxidil formulations), this drying time difference compounds. Two solution applications per day require approximately an hour of cumulative wait time. Two foam applications require ten minutes. Over twelve months, the difference in friction between the two protocols is substantial — and friction is one of the primary drivers of non-compliance.

In Malta specifically, this practical difference is amplified by the climate. During the summer months — May through September, when temperatures regularly exceed 30 degrees Celsius and humidity is moderate to high — solution applied to the scalp can feel uncomfortable once outdoor activity begins. Sweat mixes with the residual solution and can cause the product to drip onto the forehead or face. For men who spend time outdoors, exercise in the mornings, or commute on foot, this can be a genuine inconvenience that discourages consistent application. Foam, drying in minutes and leaving no residual liquid, avoids this problem almost entirely.

Cost in Malta: Solution Is Generally Cheaper

Price is a practical consideration for a treatment that must be used indefinitely to maintain results. Generic minoxidil solution has been off-patent for decades and is widely available at pharmacies at a significantly lower price point than foam formulations.

Branded foam (sold under names such as Regaine or Rogaine, depending on the market) is typically the most expensive option available over the counter. Pharmacy retail prices in Malta and across Europe can be two to three times higher per month than the equivalent volume of generic solution.

Generic solution is available at pharmacies in Malta at substantially lower cost. The active ingredient is identical to branded formulations; the only differences may be in the concentration of carrier chemicals or minor formulation variables that do not affect clinical efficacy.

Generic foam options have become increasingly available, though at present the range is narrower than for generic solution.

For patients where budget is a consideration, and where no scalp sensitivity issues have emerged with solution, the cost differential is worth factoring into a long-term compliance calculation. A treatment you can sustain financially for three to five years is more valuable than a premium formulation you discontinue after six months because of cost.

If you are uncertain about access to minoxidil in Malta — whether over-the-counter or via prescription — the full overview is available in the guide to minoxidil in Malta. For a detailed look at why the 5% concentration is the clinically recommended formulation for men, the minoxidil 5% in Malta guide covers the evidence base.

The Shedding Question

New minoxidil users frequently experience an increase in hair shedding during the first two to eight weeks of treatment. This is a recognised pharmacological effect — minoxidil accelerates the transition of resting (telogen) follicles into the active growth (anagen) phase, which physically dislodges resting hairs before new growth begins. The process is a positive indicator that the medication is biologically active, not evidence that it is failing.

The minoxidil shedding phase is covered in detail separately. In the context of formulation choice, the relevant question is whether foam or solution produces a different shed experience.

The answer, based on available clinical data, is no. The active ingredient concentration and mechanism of action are the same in both formulations. The shed phase is driven by the minoxidil molecule's effect on follicle cycling, not the carrier. A peer-reviewed minoxidil efficacy review in the British Journal of Dermatology confirms that follicle cycling responses are attributable to the active compound rather than the delivery vehicle.

Patients switching from solution to foam mid-treatment sometimes perceive a new or renewed shedding episode, which is likely attributable to improved scalp penetration and tolerability that foam offers — in effect, the scalp may be receiving more effective exposure if solution had been causing irritation that limited penetration. This perception is not well-studied but is clinically plausible.

The practical takeaway: if you switch formulations, monitor for a brief shedding episode without alarm, but do not attribute it to a deficiency in the new formulation.

Choosing for Your Situation

Most patients benefit from starting with the formulation most likely to ensure consistent twice-daily application over the first year. A few structured questions help clarify which that is:

Does your scalp react easily to topical products? If you have a history of contact dermatitis, sensitivity to cosmetic formulations, or known propylene glycol sensitivity — start with foam. Avoiding the primary irritant from day one prevents unnecessary disruption later.

Do you have dense remaining hair? If yes, solution's liquid delivery may reach the scalp more reliably without extensive parting manoeuvres. Foam can work well, but requires deliberate application technique.

What does your morning or evening routine look like? If you apply hair products, work out before leaving the house, or have limited time in the morning — foam is the more practical choice. Its rapid drying time removes the single biggest compliance friction point.

Is cost a material consideration? If yes — and there is no scalp sensitivity concern — generic solution is likely more sustainable over the multi-year time horizon that effective minoxidil therapy requires.

Do you already have scalp irritation on solution? Switch to foam promptly. Do not try to manage irritation by reducing application frequency, as inconsistent dosing reduces efficacy without reliably resolving the underlying sensitivity.

When to Switch Formulations Mid-Treatment

There are two primary scenarios in which switching formulations is clinically appropriate — and one in which it is not.

Switch from solution to foam when:

• ›Scalp redness, persistent itch, flaking, or a burning sensation develops and continues beyond two to four weeks despite correct application technique
• ›Compliance with twice-daily application is deteriorating because of drying time or summer-season discomfort
• ›The solution formulation is creating transfer issues (onto pillows, partner's skin, clothing)

Switch from foam to solution when:

• ›Application technique on dense hair is proving difficult and scalp contact is unreliable
• ›Cost is creating a sustainability problem and scalp tolerance of propylene glycol is confirmed to be unproblematic

Do not switch formulations because:

• ›Early shedding has occurred — this is expected with either formulation and not a formulation-specific problem
• ›Results are not yet visible at two to three months — minoxidil may require a minimum of four to six months of consistent use before meaningful density changes become apparent; formulation is not the relevant variable at this stage

Frequently Asked Questions About Minoxidil Foam vs Solution in Malta

Is minoxidil foam or solution more effective?

No large head-to-head randomised trial has established a definitive efficacy difference between the two formulations. Both contain the same active ingredient at the same concentration. The foam formulation avoids propylene glycol, which can cause scalp irritation in some patients and may limit the effective penetration of solution if dermatitis is present. For most patients, clinical efficacy is considered equivalent — the more important variable is consistent twice-daily application over 12 months or more. Results may vary for each individual depending on the underlying cause and pattern of hair loss.

Is minoxidil safe to use long-term?

Minoxidil has a well-established long-term safety profile and has been used clinically for male and female pattern hair loss since the 1980s. The most common side effects are scalp-related — redness, itching, or flaking — typically attributable to the propylene glycol carrier in solution rather than minoxidil itself. Switching to foam resolves most of these reactions. Systemic side effects are rare at topical doses. As with any medical treatment, a clinical assessment before starting is recommended, and any unexpected changes should be reviewed by a qualified practitioner.

Can minoxidil solution cause scalp irritation?

Yes. The most common cause of topical irritation from minoxidil solution is propylene glycol, the carrier solvent used in liquid formulations. Symptoms include redness, itching, flaking, and a burning sensation after application. This is a contact dermatitis reaction to the carrier — not necessarily an intolerance to minoxidil itself. Switching to a foam formulation, which does not contain propylene glycol, typically resolves the irritation while allowing the patient to continue treatment.

What results can I expect from minoxidil, and when?

Clinical studies indicate that meaningful hair density improvements become visible at four to six months of consistent twice-daily application. Earlier response may be obscured by the initial shedding phase in the first two to eight weeks. The choice between foam and solution does not change this timeline — the active ingredient and concentration are identical. Evidence suggests that most patients who respond to minoxidil see continued improvement at 12 months, with stabilisation or further gains beyond that. Results may vary for each individual.

How long does minoxidil foam take to dry?

Minoxidil foam typically dries within three to five minutes of application. The alcohol-based carrier evaporates quickly once dispensed, leaving the scalp comfortable and dry shortly after use. This compares favourably to minoxidil solution, which can take 20 to 30 minutes to dry fully. The difference in drying time is one of the main practical reasons patients with active morning or exercise routines prefer foam.

How much does minoxidil cost in Malta?

The cost varies by formulation and brand. Generic minoxidil solution is typically the most affordable option and is widely available at Maltese pharmacies. Branded foam (such as Regaine) can cost two to three times more per month than generic solution. Generic foam options are becoming more available but remain less common than generic solution. For a long-term treatment — which minoxidil is — factoring cost into your formulation choice is clinically sensible.

Can I switch from minoxidil solution to foam mid-treatment?

Yes. Switching between formulations mid-treatment is appropriate and does not restart the therapeutic timeline. The active ingredient and concentration remain the same. When switching from solution to foam, a brief increase in perceived shedding may occur — this is most likely because improved scalp tolerance allows more effective follicle exposure, and should not be interpreted as a sign that the treatment is failing. Continue twice-daily application and monitor for results over the following four to six months.

Do I need a prescription for minoxidil in Malta?

Minoxidil is available over the counter in Malta at both 2% and 5% concentrations. A prescription is not required to purchase it at a pharmacy. However, a clinical assessment is recommended before starting treatment — particularly if you are unsure whether androgenetic alopecia is the correct diagnosis, or if you want guidance on the appropriate formulation, concentration, and complementary treatments for your specific pattern of loss.

Making the Right Choice — and Sticking With It

Consistency of application matters more than which formulation sits on your shelf. Photo: Ron Lach / Pexels

The foam-versus-solution question is, ultimately, a question about the conditions most likely to sustain twice-daily application for twelve months and beyond. If propylene glycol sensitivity is present or likely, choose foam without hesitation. If hair density is high and budget is a constraint, start with solution and monitor for scalp tolerance. If lifestyle, climate, or convenience are your primary concerns, foam removes the main practical friction points that cause patients in Malta to miss applications.

What the clinical evidence does not support is prolonged indecision. Minoxidil's efficacy is time-dependent — the follicles that respond best to treatment are those that have not yet reached terminal miniaturisation. Waiting to choose the perfect formulation while hair loss continues is not a neutral act.

Choosing the formulation is the easy part. The harder commitment is applying it consistently, at the right concentration, for long enough to see the results clinical studies indicate are achievable. If you have remaining uncertainty about whether minoxidil is the appropriate treatment for your pattern and stage of hair loss, or whether combining it with other options may serve you better, that question is best answered through a proper clinical assessment rather than a further layer of research.

The Hair Reset Protocol at Carisma Hair Clinic integrates topical therapy — including minoxidil at the appropriate formulation and concentration for your scalp — with scalp imaging and density mapping that confirms whether follicles are responding. It removes the guesswork from both the formulation choice and the dosing decision.

Ready to Take Control of Your Hair Loss?

If you have been researching your options and want a clinical assessment rather than another generic recommendation, Carisma Hair Clinic offers a comprehensive diagnostic consultation — scalp imaging, density mapping, and a personalised protocol designed around your specific pattern of loss.

→ Book Your Free Hair Loss Consultation

Dr. Giovanni Scornavacca and the team at Carisma Hair Clinic are available at our St Julian's clinic.

About the Author

Dr. Giovanni Scornavacca is a hair restoration specialist with over 20 years of clinical experience, with advanced training at universities in Rome and Bologna. He leads the Hair Reset Protocol at Carisma Hair Clinic — Malta's most complete non-surgical hair regrowth programme. Dr. Scornavacca specialises in diagnosing and treating androgenetic alopecia, telogen effluvium, and complex hair loss presentations using a combination of PRP, exosome therapy, and prescription protocols tailored to each patient.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Results may vary for each individual. Always consult a qualified healthcare professional before starting any hair loss treatment. Dr. Giovanni Scornavacca and Carisma Hair Clinic are available for clinical consultation at our St Julian's, Malta clinic.

Written and reviewed by Dr. Giovanni Scornavacca, Carisma Hair Clinic. Published: 26 June 2026.

Ready to Take Action?

Book a free consultation with Dr. Giovanni Scornavacca to get a personalised hair loss assessment and treatment plan.